Quantum BioPharma Correlations
QNTM Stock | 4.01 0.07 1.72% |
The current 90-days correlation between Quantum BioPharma and Petros Pharmaceuticals is 0.15 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Quantum BioPharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Quantum BioPharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
Quantum BioPharma Correlation With Market
Significant diversification
The correlation between Quantum BioPharma and DJI is 0.03 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Quantum BioPharma and DJI in the same portfolio, assuming nothing else is changed.
Quantum |
Moving together with Quantum Stock
0.65 | FOLD | Amicus Therapeutics | PairCorr |
0.67 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.72 | UPC | Universe Pharmaceuticals | PairCorr |
0.65 | PAHC | Phibro Animal Health | PairCorr |
0.65 | ALNY | Alnylam Pharmaceuticals | PairCorr |
Moving against Quantum Stock
0.37 | LFCR | Lifecore Biomedical | PairCorr |
0.32 | BMY | Bristol Myers Squibb | PairCorr |
0.56 | APLS | Apellis Pharmaceuticals | PairCorr |
0.42 | ARGX | argenx NV ADR | PairCorr |
0.39 | ACAD | ACADIA Pharmaceuticals | PairCorr |
0.37 | PRFX | Painreform | PairCorr |
0.63 | CPIX | Cumberland Pharmaceuticals | PairCorr |
0.49 | BFRI | Biofrontera | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Quantum Stock performing well and Quantum BioPharma Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Quantum BioPharma's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
COLL | 1.86 | (0.43) | 0.00 | (8.57) | 0.00 | 2.95 | 12.29 | |||
PAHC | 1.64 | (0.09) | 0.00 | (0.39) | 0.00 | 3.42 | 12.19 | |||
ANIP | 1.65 | (0.10) | 0.00 | (0.28) | 0.00 | 2.64 | 9.65 | |||
PROC | 10.41 | 1.41 | 0.13 | 4.92 | 10.18 | 38.04 | 122.49 | |||
RGC | 5.72 | 0.25 | 0.04 | 0.39 | 5.87 | 19.02 | 43.32 | |||
LFCR | 3.38 | 0.78 | 0.17 | 2.78 | 3.75 | 9.76 | 24.59 | |||
PTPI | 7.43 | 0.92 | 0.09 | (0.16) | 7.22 | 20.51 | 115.19 |
Quantum BioPharma Corporate Management
Kevin Cassidy | Vice QualityLucid | Profile | |
Donal CPA | Chief Officer | Profile | |
Jason Sawyer | Head Acquisitions | Profile | |
Maryann Adesso | Corporate Secretary | Profile | |
Nathan CPA | Chief Officer | Profile |